Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Prognostic value of circulating tumor DNA for minimal residual disease detection in ovarian cancer: A systematic review and meta-analysis

Systematic review and meta-analysis of the prognostic value of ctDNA for MRD detection in ovarian cancer.

Crit Rev Oncol HematolPubMed 41895358DOI 10.1016/j.critrevonc.2026.105300